Balversa: payments to doctors
Payments that named Balversa as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $667K
- Providers
- 7,582
- Transactions
- 18,342
- Average per transaction
- $36
The per-transaction average — $36 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,582 providers the average total is $88, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $567,194 | 85.0% |
| Janssen Scientific Affairs, LLC | $59,339 | 8.9% |
| Janssen Global Services, LLC | $29,636 | 4.4% |
| Janssen Research & Development, LLC | $10,909 | 1.6% |